title: Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
abstract: Hyperparathyroidism-jaw tumor syndrome (HPT-JT) is a rare autosomal dominant hereditary tumor syndrome characterized by synchronous or metachronous occurrence of primary hyperparathyroidism (PHPT), ossifying fibroma of the maxilla and/or mandible, renal tumor and uterine tumors. Early diagnosis of this syndrome is essential because it is associated with increased risk of parathyroid cancer. A 30-year-old man with urolithiasis had severe hypercalcemia (15.0 mg/dL after correction) induced by inappropriate parathyroid hormone (PTH) secretion (intact PTH 1390 pg/mL), indicating severe PHPT. An underlying parathyroid tumor was surgically removed and was histologically confirmed to be an adenoma. However, PHPT due to another parathyroid tumor reoccurred two years after the surgery. Although no HPT-JT-associated manifestations other than PHPT were detected, HPT-JT was strongly suspected based on the exclusion of multiple endocrine neoplasia (MEN) and the young age of disease occurrence. Genetic analysis revealed a novel nonsense mutation (p.Arg91X; c.271C>T) in exon 3 of the causative gene, CDC73, which encodes the tumor suppressor protein parafibromin. The residual parathyroid glands were all removed without autotransplantation of parathyroid gland taking into consideration prospective parathyroid carcinogenesis. The resected parathyroid tumor was also an adenoma. The present case highlights that HPT-JT should be considered and CDC73 mutation analysis should be performed, especially in cases of early-onset PHPT, recurrent PHPT, PHPT with polyglandular parathyroid involvement, and PHPT presenting with severe hypercalcemia even if there is no positive family history.
authors.affiliation: Department of Diabetes, Endocrinology and Metabolism, Shinshu University School of Medicine, Matsumoto, 390-8621, Japan.
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Shibata
authors.forename: Masanori
authors.initials: M
authors.lastname: Yamazaki
authors.forename: Masahiro
authors.initials: M
authors.lastname: Takei
authors.forename: Shinya
authors.initials: S
authors.lastname: Uchino
authors.forename: Akihiro
authors.initials: A
authors.lastname: Sakurai
authors.forename: Mitsuhisa
authors.initials: M
authors.lastname: Komatsu
mesh_terms: D000236:Adenoma / Q000235:genetics* / Q000473:pathology; D000328:Adult; D004252:DNA Mutational Analysis; D005350:Fibroma / Q000235:genetics* / Q000473:pathology; D006801:Humans; D006961:Hyperparathyroidism / Q000235:genetics* / Q000473:pathology; D007573:Jaw Neoplasms / Q000235:genetics* / Q000473:pathology; D008297:Male; D009154:Mutation; D010375:Pedigree; D012008:Recurrence; D012720:Severity of Illness Index; D025521:Tumor Suppressor Proteins / Q000235:genetics*
chemical_list: C454900:CDC73 protein, human; D025521:Tumor Suppressor Proteins